Peptide receptor radionuclide therapy (Soricimed/Orano Med)

N/A

Report date: 2025/03/20 14:37:53

Base Information

Drug NamePeptide receptor radionuclide therapy (Soricimed/Orano Med)
Drug Alias Namelead-212 labeled TRPV6 (Soricimed/Orano Med)
ClassificationRadiation-emitting products > Radioactive therapeutic agentBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 6 modulators
TargetsTransient receptor potential cation channel subfamily V member 6
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSoricimed Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSoricimed Biopharma Inc
Inactive CompaniesOrano Med Llc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A